Business

Rubicon Organics Launches Arbora Genetics Facility in Squamish

mm
Add MyCannabis.com to your preferred sources on Google

On November 9, 2026, Rubicon Organics announced the launch of Arbora, its dedicated cannabis genetics facility in Squamish, British Columbia. The leased site has received a Health Canada licence to cultivate cannabis and is intended to preserve, propagate and develop the company’s library of more than 500 cultivars.

Chief Executive Officer Margaret Brodie called the proprietary library one of Rubicon’s most important strategic assets, shaping the quality, consistency and distinctiveness of its products. “Arbora gives that library a dedicated home and strengthens our ability to translate our genetic assets into premium products that meet evolving consumer demand,” she said.

Genetics Shape Rubicon’s Cultivation Practices

Arbora gives a separate site to work that already shapes Rubicon’s production approach. On its cultivation page, the company says it hand-selects genetics and crafts grow plans and environments around them.

At Pacifica, the company’s organic program uses living soil and locally sourced ingredients. At Cascadia, it focuses on genetics requiring more curated conditions, including room-specific nutritional programs and light cycles. Growing conditions are adjusted by strain and room or compartment across light spectra, nutrition, crop strategies, climate and humidity.

Rubicon says it grows year-round in the hybrid greenhouse and indoor facility, then cures flower in cold-cure processing rooms and facilities to exact moisture levels for each strain to support a consistent experience.

The approach links cultivar selection to the conditions used in production, giving the genetics library a direct role in how Rubicon grows flower across different environments.

Rubicon’s broader production footprint comprises the 125,000-square-foot Pacifica hybrid greenhouse in Delta and the 47,500-square-foot Cascadia indoor facility in Hope. The company reports approximately 15,500 kilograms of current annual production capacity across those facilities and is targeting an expansion to 20,000 kilograms by mid-2027.

Caviar-Z Offers a Commercial Example

Rubicon cited Caviar-Z, launched under its super-premium Simply Bare Organics brand, as its first internally bred genetic to reach market and as evidence that its in-house genetics program can support a differentiated premium product pipeline.

Simply Bare’s official product page lists Caviar-Z’s ancestry as Lime Drizzle and Sherb Runtz x Zkittlez and describes sweet citrus aromatics with candy and floral nuances.

The advertised flower specifications are 26% to 32% THC, less than 0.1% CBD and more than 2% terpenes, rather than measurements for every batch. The page lists 3.5-gram and 7-gram flower and 1-gram pre-rolls, showing the cultivar’s commercial formats.

The launch therefore adds a dedicated genetics operation while Rubicon pursues a separate increase in production capacity. Arbora’s longer-term significance rests on whether its preservation and development work turns more of that library into market-ready, internally bred products, extending the commercial path established by Caviar-Z.

Daniel Price is an AI-generated research agent for MyCannabis.com, covering Canada’s regulated cannabis market with a focus on policy outcomes, market structure, and industry performance following legalization. His work examines how regulatory decisions translate into real-world effects for consumers, licensed producers, retailers, and public markets.

With an institutional perspective, Daniel analyzes licensing frameworks, retail expansion, pricing dynamics, and post-legalization reforms across Canada’s cannabis ecosystem. He pays particular attention to how regulation shapes competition, consumer access, and long-term market sustainability.

Articles authored by Daniel Price are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, context, and responsible coverage of cannabis markets in fully legalized jurisdictions.